This is a working overview of Stability testing, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-11-24 and is reviewed periodically as new material appears.
Identity and purity of NMN are commonly assessed by liquid chromatography with ultraviolet detection or mass spectrometry. High-performance liquid chromatography can separate related impurities such as nicotinamide, nicotinamide riboside, and NAD+ depending on the method. Mass spectrometry provides molecular mass confirmation, while nuclear magnetic resonance spectroscopy helps establish structure and anomeric form. Quantitative assays often use calibration curves and, in biological samples, stable isotope-labeled internal standards. Method validation addresses specificity, linearity, accuracy, precision, and limits of detection.
Quality control for NMN materials typically includes appearance, assay, impurity profile, residual solvents, heavy metals, and microbial limits. A certificate of analysis summarizes specified tests, but the underlying methods and laboratory accreditation matter. Regulatory treatment varies by country; NMN is sold as a dietary supplement in some markets, while other jurisdictions restrict its use in foods or classify it differently. Independent verification can reduce risks of mislabeling or substitution. Questions remain about how product purity, storage history, and formulation affect delivered dose in humans.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide found in cells. Its structure consists of a nicotinamide ring linked to ribose phosphate, and the compound serves as an intermediate in the salvage pathway for nicotinamide adenine dinucleotide, or NAD+. In this pathway, nicotinamide phosphoribosyltransferase converts nicotinamide and phosphoribosyl pyrophosphate into NMN, after which NMN adenylyltransferase attaches an adenylate group to produce NAD+. Because NAD+ participates in redox reactions and signaling, NMN occupies a central position in cellular metabolism. The molecule is distinct from nicotinamide riboside, though the two are related in NAD+ precursor research.
Beyond its intracellular synthesis, NMN can be taken up from the extracellular environment, although the routes are still debated. Some evidence points to direct transport into cells through specific transporters, while other work suggests dephosphorylation to nicotinamide riboside followed by cellular uptake. Once inside, NMN can be converted to NAD+ by NMN adenylyltransferases; the relative contribution of these routes may differ by tissue, species, and experimental conditions. Researchers continue to investigate which mechanisms dominate in intact organisms and how they affect measured NAD+ levels. Direct measurement in tissues remains technically challenging because NMN can be rapidly metabolized during sample collection.
NMN occurs in many living systems, including bacteria, yeast, plants, and mammals. Dietary sources are present in foods such as edamame, avocado, broccoli, and various meats, but amounts vary widely and are generally lower than those used in research settings. Laboratory production often relies on enzymatic synthesis or chemical phosphorylation of nicotinamide riboside, and commercial material is typically supplied as a white to off-white powder. Because NMN is hygroscopic and sensitive to heat, moisture, and pH extremes, its handling requires care to preserve identity and purity. Aqueous preparation should be done with attention to pH and temperature to limit hydrolysis.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Visual description varies by grade |
| Solubility class | Freely soluble in water | Polar nucleotide; less soluble in organic solvents |
| Typical storage temperature | -20°C or below | Protect from moisture and light; desiccated |
| Common analytical method | HPLC-UV or LC-MS | Used for identity and purity; NMR for structure |
| Hygroscopicity | Hygroscopic | Absorbs moisture; keep sealed |
Stability studies indicate that NMN is sensitive to heat, light, and pH extremes. In aqueous solution, hydrolysis can cleave the phosphate linkage or convert NMN to related nicotinamide derivatives, with degradation accelerating at elevated temperatures and alkaline conditions. Solid material is generally more stable when kept dry and cold, and research-grade supplies are often stored at minus twenty degrees Celsius or lower, protected from light and moisture. Repeated freeze-thaw cycles of solutions can promote degradation, so aliquoting is a common laboratory practice. The exact shelf life depends on purity, counterion, packaging, and storage history.
Quality control for NMN focuses on identity, purity, and the absence of harmful contaminants. Certificates of analysis may report high-performance liquid chromatography purity, mass spectrometry identity, residual solvents, heavy metals, and microbial limits, depending on grade and intended use. Because NMN can exist as different isomers, salts, or hydrates, specification sheets should state the exact form being tested. There is no single globally harmonized purity standard for NMN products. Open questions include which degradation products are most relevant under real-world storage and how analytical results from different laboratories can be compared reliably.
Analytical measurement of NMN typically uses reversed-phase high-performance liquid chromatography with ultraviolet detection near 260 nm. Mass spectrometry, often coupled to liquid chromatography, provides sensitive quantification and confirmatory identification in biological matrices. Nuclear magnetic resonance spectroscopy is used to verify molecular structure and distinguish related nucleotides. Because NMN is polar and poorly retained on conventional reversed-phase columns, ion-pairing reagents or hydrophilic interaction chromatography are sometimes employed. Reported purity values depend on the chosen method, calibration standard, and whether related substances are resolved.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide. Its structure combines a nicotinamide ring, a ribose sugar, and a phosphate group. The compound exists in cells as an intermediate in the production of nicotinamide adenine dinucleotide, a central redox cofactor. NMN is distinct from nicotinamide riboside, another related pyridine nucleotide, although the two compounds can converge in metabolic pathways. Its chemical formula is C11H15N2O8P, and it carries a net negative charge at physiological pH.
In the salvage pathway, NMN is generated from nicotinamide and 5-phosphoribosyl-1-pyrophosphate by the enzyme nicotinamide phosphoribosyltransferase. A second route produces NMN from nicotinamide riboside through phosphorylation by nicotinamide riboside kinases. NMN is then converted to NAD+ by nicotinamide mononucleotide adenylyltransferases, often called NMNAT enzymes. This stepwise route allows cells to recycle nicotinamide and maintain NAD+ levels under changing metabolic conditions. The relative contribution of each route varies by tissue, species, and physiological state, and it remains an active area of research.
Research on NMN has expanded because NAD+ concentrations decline with age in some tissues and because NAD+ participates in energy metabolism, DNA repair, and signaling. Animal studies have reported changes in NAD+ levels after NMN administration, but human data are more limited and often focus on safety, pharmacokinetics, and biomarker changes. Questions remain about oral absorption, tissue distribution, and whether changes in blood NAD+ reflect changes inside specific organs. NMN is not an approved drug, and claims about its clinical effects should be distinguished from established biochemical findings.
First, it exists to exploit the author-pays Open Access model to generate revenue, and second, it serves as an easy place for foreign (chiefly Chinese) authors to publish overseas and increase their academic status." He acknowledges that its fees are relatively low, describing this as "a strategy that increases article submissions," and that "it has attracted some quality article submissions. Nevertheless, it is really a vanity press." Further controversy was generated by a mass resignation of the editorial board of one of the company's journals, Advances in Anthropology, in 2013. According to the former editor-in-chief, Fatimah Jackson, it was motivated by failures to include the editorial board in the journal's review process, and by "consistent and flagrant unethical breaches by the editorial staff in China", for whom publishing the journal "was only about making money." According to Beall, this was the first mass resignation from an open-access journal. In 2021 Cabells' Predatory Reports described SCIRP as a "well-known predatory publisher". In the Norwegian Scientific Index, the publisher and all of its journals have a rating of 0 (non-academic). An academic study published in 2022 stated that SCIRP was "widely known to host 'fake journals'".
== Personal life == Carlisle grew up in Craigieburn, a northern suburb of Melbourne. He is the second youngest of five children and has four sisters. He attended Willmott Park Primary School in Craigieburn before going to Niddrie Secondary College. Carlisle has several tattoos. He has an ambigram tattoo of "mother" and "Darlene" on his arm, "Carlisle" on the right side of his back and his sisters' names on his ribs.
== Contraindications == Oclacitinib is not labeled for use in dogs younger than one year due to reports of it causing demodicosis. It should also be avoided in dogs less than 3 kg (6.6 lb). Most of the other contraindications are avoiding cases where a potential side effect exacerbates a pre-existing condition: for example, because oclacitinib can cause lumps or tumors, it should not be used in dogs with cancer or a history of it; because it is an immune system suppressant, it should not be used in dogs with serious infections. Oclacitinib, by virtue of its low plasma protein binding, has little chance of reacting with other drugs. Nonetheless, concurrent use of steroids and oclacitinib has not been tested and is thus not recommended.
Sources: en.wikipedia.org
=== EC 2.7.4: Phosphotransferases with a phosphate group as acceptor === EC 2.7.4.1: ATP-polyphosphate phosphotransferase EC 2.7.4.2: phosphomevalonate kinase EC 2.7.4.3: adenylate kinase EC 2.7.4.4: nucleoside-phosphate kinase EC 2.7.4.5: deleted, now included with EC 2.7.4.14 cytidylate kinase EC 2.7.4.6: nucleoside-diphosphate kinase EC 2.7.4.7: phosphomethylpyrimidine kinase EC 2.7.4.8: guanylate kinase EC 2.7.4.9: dTMP kinase EC 2.7.4.10: nucleoside-triphosphate—adenylate kinase EC 2.7.4.11: (deoxy)adenylate kinase EC 2.7.4.12: T2-induced deoxynucleotide kinase EC 2.7.4.13: (deoxy)nucleoside-phosphate kinase EC 2.7.4.14: cytidylate kinase EC 2.7.4.15: thiamine-diphosphate kinase EC 2.7.4.16: thiamine-phosphate kinase EC 2.7.4.17: 3-phosphoglyceroyl-phosphate—polyphosphate phosphotransferase EC 2.7.4.18: farnesyl-diphosphate kinase EC 2.7.4.19: 5-methyldeoxycytidine-5′-phosphate kinase EC 2.7.4.20: dolichyl-diphosphate—polyphosphate phosphotransferase EC 2.7.4.21: inositol-hexakisphosphate kinase EC 2.7.4.22: UMP kinase EC 2.7.4.23: ribose 1,5-bisphosphate phosphokinase EC 2.7.4.24: diphosphoinositol-pentakisphosphate kinase EC 2.7.4.25: (d)CMP kinase EC 2.7.4.26: isopentenyl phosphate kinase EC 2.7.4.27: [pyruvate, phosphate dikinase]-phosphate phosphotransferase EC 2.7.4.28: [pyruvate, water dikinase]-phosphate phosphotransferase EC 2.7.4.29: Kdo2-lipid A phosphotransferase EC 2.7.4.30: Now EC 2.7.8.43, lipid A phosphoethanolamine transferase EC 2.7.4.31: [5-(aminomethyl)furan-3-yl]methyl phosphate kinase EC 2.7.4.32: farnesyl phosphate kinase EC 2.7.4.33: AMP-polyphosphate phosphotransferase EC 2.7.4.34: GDP-polyphosphate phosphotransferase
== Controversies and legal troubles == In June 2016, Bay Area bands Wax Idols and King Woman abruptly ended their tour with Pentagram, citing instances of harassment and unprofessional conduct. Hether Fortune of Wax Idols and Kristina Esfandiari of King Woman stated that they and their bandmates had been "treated really poorly & harassed in gross ways," leading them to withdraw from the tour. Pentagram's management labeled the situation as "unfounded and grossly opportunistic," claiming that after a few nights on tour, the bands "simply disappeared, posted negatively about us on social media, and then headed over to the show that was previously set up for them that very night." In 2017, Liebling was arrested and charged with first-degree assault and physical abuse/injury of a vulnerable adult, later revealed to be his, at the time, 87-year-old mother Diane Liebling. He entered into a plea agreement, resulting in him pleading guilty to the abuse/neglect charge while maintaining his innocence regarding the first-degree assault charge. In October 2017, Liebling was sentenced to eighteen months in the Montgomery County Detention Center and three years of probation upon release. During Liebling's incarceration, Pentagram continued their US tour and performed in Europe without him, with Victor Griffin taking over on vocals. Previously, Liebling had been charged once for violating a restraining order and multiple times for drug possession.
== Inside the body == Hemolysis inside the body can be caused by a large number of medical conditions, including some parasites (e.g., Plasmodium), some autoimmune disorders (e.g., autoimmune haemolytic anaemia), drug-induced hemolytic anemia, atypical hemolytic uremic syndrome (aHUS)), some genetic disorders (e.g., Sickle-cell disease or G6PD deficiency), or blood with too low a solute concentration (hypotonic to cells). Hemolysis can lead to hemoglobinemia due to hemoglobin released into the blood plasma, which plays a significant role in the pathogenesis of sepsis and can lead to increased risk of infection due to its inhibitory effects on the innate immune system.
The same Stictis fungus can form a lichen when algae are present (it was formerly classified in a separate lichen genus, Conotrema) or live as a saprobe (decay organism) when absent—yet in both cases it retains the same Latin name. These cases underscore that the mycobiont is the nomenclatural unit; the lichen is its ecological expression. The holobiont lens nonetheless shifts research toward how fungal–algal–microbial associations evolve. Topics such as photobiont switching—common among closely related Trebouxia strains but rare between major algal lineages—are tested for links with adaptation and speciation. Photobiont flexibility — a fungus's ability to switch algal partners — appears to vary. Many lichen-forming fungi can pair with multiple algae of the same general type (for example, different strains of Trebouxia, a genus of green algae). However, switching to a completely different type of algal partner (say, from a green alga to a cyanobacterium) is much rarer, and often coincides with a major evolutionary shift in the lichen.
Sources: en.wikipedia.org
Furin is a protease, a proteolytic enzyme activated by substrate presentation that in humans and other animals is encoded by the FURIN gene. Some proteins are inactive when they are first synthesized, and must have sections removed in order to become active. Furin cleaves these sections and activates the proteins. It was named furin because it was in the upstream region of an oncogene known as FES. The gene was known as FUR (FES Upstream Region) and therefore the protein was named furin. Furin is also known as PACE (Paired basic Amino acid Cleaving Enzyme). A member of family S8, furin is a subtilisin-like peptidase.
== History == The company was founded in Bremen on 24 October 1923 as Bremer Flugzeugbau AG by Prof. Henrich Focke, Georg Wulf and Dr. rer. pol. Werner Naumann. Almost immediately, they renamed the company Focke-Wulf Flugzeugbau AG (later Focke-Wulf Flugzeugbau GmbH). Focke-Wulf merged, under government pressure, with Albatros Flugzeugwerke of Berlin in 1931. The Albatros Flugzeugwerke engineer and test pilot Kurt Tank became head of the technical department and started work on the Fw 44 Stieglitz (Goldfinch). Dr Ludwig Roselius became chairman in 1925 and handed over to his brother Friedrich in early 1933. In 1938 Roselius' HAG combine increased its shareholding to 46% and C. Lorenz AG secured 28%. The company was reconstituted as Focke-Wulf Flugzeugbau GmbH and no longer had to publish its accounts. A substantial capital injection occurred at this time. In August 1933 Hans Holle and Rudolf Schubert were given power of attorney over the Berlin branch of Focke-Wulf. Then in October 1933, Focke-Wulf Flugzeugbau A.G. Albatros Berlin was officially registered with the Department of Trade. Dr Roselius always remained the driving force of Focke-Wulf. He and his closest collaborator, Barbara Goette, often met with technical director Professor Kurt Tank. When Roselius died in May 1943, Heinrich Puvogel (later chair of Focke-Wulf) raised 4 million RM and continued handling the financial affairs of Focke-Wulf as chief of Seehandel A.G. Hanna Reitsch demonstrated the Focke-Wulf Fw 61, the first fully controllable helicopter (as opposed to autogyro), in Berlin in 1938.
Potential graphene applications include lightweight, thin, and flexible electric/photonics circuits, solar cells, and various medical, chemical and industrial processes enhanced or enabled by the use of new graphene materials, and favoured by massive cost decreases in graphene production.
Sources: en.wikipedia.org
Solid NMN is often stored frozen, desiccated, and protected from light. Aqueous solutions are less stable and generally require colder storage or fresh preparation.
Mass spectrometry and nuclear magnetic resonance spectroscopy are used for structural confirmation. Liquid chromatography with ultraviolet or mass spectrometric detection is common for purity and quantity.
No. Chemical purity indicates the material matches specification; it does not demonstrate absorption, biological activity, or clinical benefit. Those questions require controlled human studies.
NMN is nicotinamide mononucleotide, a nucleotide intermediate in NAD+ biosynthesis. It consists of nicotinamide, ribose, and phosphate groups.